Abstract: Human physiology and disease are defined by complex interactions between genetic and environmental factors. While genome-wide association studies (GWASs) have been successfully used to dissect many human traits, they have not worked for studies of the heart. This likely reflects the limitations in echocardiographic and traditional magnetic resonance phenotyping, as many cardiac traits are known to be highly heritable. In an attempt to overcome the limitations of human heart GWASs to date, we developed high-resolution 3D-cardiac MRI (3D-CMR) techniques combined with computational image analysis and dense genotyping to examine the common genetic determinants of cardiac structure and function.
Introduction
The genetic architecture of the human heart has long remained elusive. Despite high heritability estimates for cardiac traits, traditional Genome-Wide Association Studies (GWAS) have struggled to identify significant genetic loci. This discrepancy is largely attributed to the limitations of standard clinical phenotyping. Conventional metrics, such as Left Ventricular (LV) mass or Ejection Fraction, rely on 2D echocardiography or MRI, which collapse the heart's complex 3D geometry into global averages. These "global" metrics often mask regional variations where genetic signals are most concentrated.
Methods
To address this, researchers utilized the Digital Heart Project, a study of 1,850 healthy volunteers (55% female, mean age 41). Participants underwent high-spatial resolution 3D cardiac MRI (3D-CMR). Using atlas-based computational anatomy, the team generated 3D models for each subject, extracting anatomical and functional parameters (such as wall thickness, stress, and curvature) at over 46,000 points across the myocardium.
To handle the resulting high-dimensional dataset, Bayesian latent factor analysis was employed to compress the 46,000 data points into 100 informative "factors" representing the primary modes of variation in heart shape and function. These factors, along with traditional 2D metrics, were then subjected to linear mixed model association analysis against 9.4 million genetic variants imputed from the UK10K and 1000 Genomes panels.
Results and Key Insights
The 3D-CMR approach proved significantly more sensitive than traditional methods. The study identified more than 10 genome-wide significant loci associated with regional differences in LV wall thickness and function. In contrast, GWAS using standard 2D metrics yielded few significant associations, proving that high-fidelity phenotyping is essential for genetic discovery in complex organs.
A critical finding was the regional nature of genetic influence. Common genetic variations do not typically alter the entire heart uniformly; instead, they affect specific anatomical regions. For instance, certain SNPs showed strong associations with wall thickness in the septum while having negligible effects on the lateral wall.
Many of the identified loci are located near genes essential for cardiac development, suggesting that adult phenotypic variations are rooted in embryonic morphogenesis. The identified regions appeared in contiguous, biologically logical clusters within the ventricle, reinforcing the biological plausibility of the findings.
Discussion and Future Work
While the sample size of 1,850 is modest for a GWAS, the discovery of multiple significant loci highlights the power of high-fidelity 3D phenotyping. Future research will focus on scaling these automated 3D segmentation pipelines to larger cohorts, such as the UK Biobank, to identify rarer variants. Furthermore, investigating how these regional genetic signatures correlate with the progression of heart disease or cardiomyopathies will be essential for clinical translation.
Conclusion
By moving beyond global averages to high-resolution 3D mapping, this study provides a new framework for understanding the genetic determinants of cardiac structure. This approach demonstrates that the "missing" heritability in cardiac traits was largely a matter of measurement precision, opening new avenues for precision medicine in cardiovascular health.
Summary updated